ALT Q3 2019 Earnings — Altimmune, Inc. Revenue & Financial Results | Market Cap Arena

ALTAltimmune, Inc.

$331M

Q3 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$643,978-75.6% YoY

Gross Profit

-$8M-1255.6% margin

Operating Income

-$11M-1750.6% margin

Net Income

-$11M-1698.7% margin

EPS (Diluted)

$-0.74

QoQ Revenue Growth

-60.4%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$2M

Stock-Based Comp.

$287,774

Balance Sheet

Total Assets

$56M

Total Liabilities

$7M

Stockholders' Equity

$49M

Cash & Equivalents

$11M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$643,978	$3M	-75.6%
Gross Profit	-$8M	-$2M	-286.1%
Operating Income	-$11M	-$4M	-177.8%
Net Income	-$11M	-$2M	-365.3%